Benzinga's Top Upgrades, Downgrades For December 12, 2018

Citigroup upgraded Lululemon Athletica inc. LULU from Neutral to Buy. Lululemon shares rose 2.5 percent to $119.80 in pre-market trading.
Cantor Fitzgerald upgraded Corcept Therapeutics Incorporated CORT from Neutral to Overweight. Corcept Therapeutics shares rose 5.2 percent to $18.06 in pre-market trading.
Citigroup upgraded Realty Income Corp O from Sell to Neutral. Realty Income shares rose 0.97 percent to close at $66.30 on Tuesday.

Morgan Stanley downgraded eBay Inc EBAY from Overweight to Equal-Weight. eBay shares fell 1.3 percent to $28.67 in pre-market trading.
Citigroup downgraded Marriott International Inc MAR from Buy to Neutral. Marriott shares rose 0.6 percent to $110.72 in pre-market trading.
JP Morgan downgraded Mosaic Co MOS from Overweight to Neutral. Mosaic shares fell 0.6 percent to close at $33.00 on Tuesday.
Keefe Bruyette & Woods downgraded Bank of America Corp BAC from Outperform to Market Perform. Bank of America shares rose 1.1 percent to $24.84 in pre-market trading.
Morgan Stanley downgraded Verizon Communications Inc. VZ from Overweight to Equal-Weight. Verizon shares fell 1.8 percent to $57.80 in pre-market trading.
Citigroup downgraded Hyatt Hotels Corporation H from Buy to Neutral. Hyatt shares rose 1 percent to $68.10 in pre-market trading.
JP Morgan downgraded Waters Corporation WAT from Neutral to Underweight. Waters shares rose 0.4 percent to $190.59 in pre-market trading.

Analysts at Oppenheimer initiated coverage on GW Pharmaceuticals PLC- ADR GWPH with a Perform rating. The price target for GW Pharmaceuticals is set to $142. GW Pharmaceuticals shares closed at $122.99 on Tuesday.
Bank of America initiated coverage on Foamix Pharmaceuticals Ltd FOMX with a Buy rating. The price target for Foamix Pharmaceuticals is set to $11. Foamix Pharmaceuticals shares closed at $3.81 on Tuesday.
B. Riley FBR initiated coverage on Madrigal Pharmaceuticals Inc MDGL with a Neutral rating. The price target for Madrigal Pharmaceuticals is set to $124. Madrigal Pharmaceuticals shares closed at $114.63 on Tuesday.
Oppenheimer initiated coverage on Jazz Pharmaceuticals PLC JAZZ with an Outperform rating. The price target for Jazz Pharmaceuticals is set to $180. Jazz Pharmaceuticals shares closed at $140.38 on Tuesday.
B. Riley FBR initiated coverage on Intercept Pharmaceuticals Inc ICPT with a Buy rating. The price target for Intercept Pharmaceuticals is set to $155. Intercept Pharmaceuticals shares closed at $104.59 on Tuesday.
Canaccord Genuity initiated coverage on BioScrip Inc BIOS with a Buy rating. The price target for BioScrip is set to $5. BioScrip shares closed at $3.85 on Tuesday.